Alterity Therapeutics Ltd. Sponsored ADR Stock
Alterity Therapeutics Ltd. Sponsored ADR Stock price
Key metrics
| Market capitalization | $63.89m |
| Enterprise Value | $61.15m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 7.73 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-15.73m |
| Free Cash Flow (TTM) Free Cash Flow | $-10.89m |
| EPS (TTM) EPS | $-1.58 |
Is Alterity Therapeutics Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
Alterity Therapeutics Ltd. Sponsored ADR Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Alterity Therapeutics Ltd. Sponsored ADR:
Analyst Opinions
1 Analyst has issued a forecast Alterity Therapeutics Ltd. Sponsored ADR:
Financial data from Alterity Therapeutics Ltd. Sponsored ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.10 -0.10 |
25%
25%
|
|
| EBITDA | -16 -16 |
46%
46%
|
EBIT (Operating Income) EBIT | -16 -16 |
46%
46%
|
| Net Profit | -13 -13 |
60%
60%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Alterity Therapeutics Ltd. Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Alterity Therapeutics Ltd. Sponsored ADR Stock News
Company Profile
Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
| Head office | Australia |
| CEO | David Stamler |
| Employees | 10 |
| Founded | 1997 |
| Website | www.alteritytherapeutics.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
